-
Intracranial Aneurysm Embolization Assist Stent Approved for Marketing
2025-02-19
Recently, the innovative product "Intracranial Aneurysm Embolization Assist Stent" of Shanghai HeartCare Medical Technology Co., Ltd. is approved by China NMPA.
-
Innovative Neurosurgical Planning Software Approved for Marketing
2025-02-19
Recently, the innovative product "Neurosurgical Planning Software" of Sinovation (Beijing) Medical Technology Co., Ltd. is approved by China NMPA. This marks the 300th innovative medical device to receive approval.
-
DBS Lead Approved for Marketing
2025-02-19
Recently, the innovative product "DBS Lead" of Boston Scientific Neuromodulation Corporation is approved by China NMPA.
-
Zirconia Ceramic Femoral Head Approved for Marketing
2025-02-19
Recently, the innovative product "Zirconia Ceramic Femoral Head" of Beijing Arthrone Technology Co., Ltd. is approved for marketing by China NMPA.
-
Implantable Cardiac Pacing Lead Approved for Marketing
2025-02-19
Recently, the innovative product "Implantable Cardiac Pacing Lead" of MicroPort Sorin CRM (Shanghai) Co., Ltd. is approved for marketing by China NMPA.
-
Management Requirements for Temporary Import and Use of Medical Devices in Urgent Clinical Need in Medical Institutions Issued and Implemented
2025-02-19
In order to fully implement the Regulations for the Supervision and Administration of Medical Devices (State Council Decree No. 739), and to further meet the demand for specific medical devices in urgent clinical need, the National Medical Products Administration (NMPA), in collaboration with the National Health Commission, has issued the Management Requirements for Temporary Import and Use of Medical Devices in Urgent Clinical Need in Medical Institutions (Announcement No. 97 of 2024, hereinafter referred to as the Management Requirements).
